Document is current
Any future updates will be listed below
-
Authors
Ekman Schenberg, Eduardo https://orcid.org/0000-0001-7111-9891
King IV, Franklin https://orcid.org/0009-0007-4928-7873
Haberkamp, Marion https://orcid.org/0009-0009-8835-1481
- License Information
-
More Information
Article History
First Online: 24 February 2026
Competing interests
: E.E.S. was scientific advisor to Ocama Partners between August 2021 and July 2023. F.K. declares Cybin and Compass personal stock, serving as Apex Labs scientific advisor and receiving research support from Tryp Therapeutics, Unlikely Collaborators and the David Borsook Project. M.H. declares no competing interests.
